| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Chairman &CEO
1 company
Patel Sanj K is a Chairman &CEO at KNSA. Recent filings cover 0 purchases and 39 sales.
Our model assigns Patel Sanj K a below-average insider score of 38/100, based on 16 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -66.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 48,565 | $54.02 | $2,623,481.30 | -100% | +41.5% | - | |
| Apr 30, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 508,339 | $51.96 | $26,415,228.13 | -100% | +50.5% | - | |
| Apr 6, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 7,278 | $50.01 | $363,972.78 | -100% | +26.7% | - | |
| Oct 22, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 257,969 | $38.86 | $10,023,531.59 | -69.8% | +5.5% | +107.7% | |
| May 28, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 86,270 | $27.24 | $2,349,981.45 | -47.2% | +23.1% | +86.5% | |
| May 20, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 2,349 | $27.02 | $63,469.98 | -2.4% | +26.3% | +103.3% | |
| May 13, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 2,872 | $27.03 | $77,630.16 | -2.9% | +27.9% | +130.9% | |
| May 9, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 8,095 | $27.04 | $218,866.45 | -7.7% | +27.2% | +125.1% | |
| Nov 6, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 89,561 | $23.00 | $2,059,903.00 | -53.0% | -18.6% | +67.7% | |
| Jul 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chairman &CEO | Sale+OE | 136,124 | $25.65 | $3,491,947.24 | -68.4% | -1.5% | +3.2% |